Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.95
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
0.92
-2.91%
After-hours: Aug 14, 2025, 07:30 PM EDT

Biofrontera Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
37.3M 34.07M 28.67M 24.1M
Cost of Revenue
18.61M 17.44M 15.19M 12.74M
Gross Profit
18.7M 16.63M 13.49M 11.36M
Operating Income
-17.21M -22.68M -22.38M -25.85M
Interest Income
30K 132K 175K 16K
Pretax Income
-17.74M -20.12M -608K -37.66M
Net Income
-17.76M -20.13M -640K -37.71M
Selling & General & Admin
33.84M 39.13M 35.87M 37.21M
Research & Development
2.09M 77K n/a n/a
Other Expenses
n/a 100K n/a n/a
Operating Expenses
35.92M 39.3M 35.87M 37.21M
Interest Expense
2.11M 600K 370K 360K
Selling & Marketing Expenses
n/a 1.43M n/a n/a
Cost & Expenses
54.53M 56.75M 47.26M 49.3M
Income Tax Expense
22K 14K 32K 56K
Shares Outstanding (Basic)
5.52M 1.55M 1.06M 855.24K
Shares Outstanding (Diluted)
5.52M 1.55M 1.06M 855.24K
EPS (Basic)
-3.22 -13.02 -0.61 -44.1
EPS (Diluted)
-3.22 -13.02 -0.61 -44.1
EBITDA
-14.44M -18.45M 934K -36.76M
EBIT
-15.63M -19.52M -238K -37.3M
Depreciation & Amortization
1.15M 1.06M 1.17M 540K